Source: Annual Congress 2002 - Pulmonary thromboembolism and pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. R. Frangulyan (Yerevan, Armenia). New aspects of pharmacological correction of pulmonary hypertension in COPD patients. Eur Respir J 2002; 20: Suppl. 38, 1538

Member's Comments

No comment yet.

Related content which might interest you: Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD? Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 The effectiveness of pulmonary rehabilitation in Russian patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009 Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006 microRNA profile in COPD patients with and without pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease> Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 272-282 Year: 2015 Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 New markers of endothelial dysfunction in patients with bronchial asthma with and without pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017 Year: 2017 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Effects of pulmonary rehabilitation on different outcomes and at different times in subjects suffering from stable COPD Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation Year: 2006 Treatment options for paediatric pulmonary arterial hypertension Source: Eur Respir Rev 2010 19: 321-330 Year: 2010 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Gender-related differences in pulmonary hemodynamics in patients with end-stage COPD Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results) Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015